23rd Mar 2015 10:04
LONDON (Alliance News) - Premaitha Health PLC said Monday it has been awarded a three-year contract to provide its non-invasive prenatal test, known as IONA, to St George's University Hospitals NHS Foundation Trust.
The test is currently the subject of a patent infringement suit filed by NASDAQ listed Illumina Inc last Monday.
The contract was awarded following a competitive tender process, and under the contract St George's Hospital in South West London will be the first National Health Service facility to offer non-invasive prenatal testing in-house.
The test uses a sample of maternal blood to estimate the risk of a foetus having serious genetic disorders.
"This award by St George's is a strong endorsement of the robustness, reliability and accuracy of the IONA test and we are pleased to be able to collaborate with the Trust to make the many benefits of NIPT a reality for pregnant women and clinicians within the UK," said Chief Executive Officer Stephen Little in a statement.
No financial details of the contract were disclosed.
Shares in Premaitha are trading up 11.8% at 20.40 pence Monday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health